CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Vol. 59 / RR-4 Recommendations and Reports 31<br />
467. Nilsson LO, Victor A, Kral JG, Johansson ED, Kock NG. Absorption of<br />
an oral contraceptive gestagen in ulcerative colitis be<strong>for</strong>e and after proctocolectomy<br />
and construction of a continent ileostomy. Contraception<br />
1985;31:195–204.<br />
468. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence<br />
of deep venous thrombosis and pulmonary embolism among patients<br />
with inflammatory bowel disease: a population-based cohort study.<br />
Thromb Haemost 2001;85:430–4.<br />
469. Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis<br />
in women infected with hepatitis C: long-term benefit of estrogen<br />
exposure. Hepatology 2004;40:1426–33.<br />
470. Libbrecht L, Craninx M, Nevens F, Desmet V, Roskams T. Predictive<br />
value of liver cell dysplasia <strong>for</strong> development of hepatocellular carcinoma<br />
in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.<br />
Histopathology 2001;39:66–73.<br />
471. Eisalo A, Konttinen A, Hietala O. Oral contraceptives after liver disease.<br />
Br Med J 1971;3:561–2.<br />
472. Peishan Wang, Zemin Lai, Jinlan Tang, et al. Safety of hormonal<br />
steroid contraceptive use <strong>for</strong> hepatitis B virus carrier women.<br />
Pharmacoepidemiol Drug Saf 2000;9:245–6.<br />
473. Shaaban MM, Hammad WA, Fathalla MF, et al. Effects of oral contraception<br />
on liver function tests and serum proteins in women with<br />
past viral hepatitis. Contraception 1982;26:65–74.<br />
474. Schweitzer IL, Weiner JM, McPeak CM, Thursby MW. Oral contraceptives<br />
in acute viral hepatitis. JAMA 1975;233:979–80.<br />
475. D’halluin V, Vilgrain V, Pelletier G, et al. Natural history of focal<br />
nodular hyperplasia. A retrospective study of 44 cases [in French].<br />
Gastroenterol Clin Biol 2001;25:1008–10.<br />
476. Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal<br />
nodular hyperplasia of the liver. Gastroenterology 2000;118:560–4.<br />
477. Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, et al. Oral and transdermal<br />
hormonal contraception in women after kidney transplantation.<br />
Transplant Proc 2007;39:2759–62.<br />
478. Pietrzak B, Kaminski P, Wielgos M, Bobrowska K, Durlik M.<br />
Combined oral contraception in women after renal transplantation.<br />
Neuro Endocrinol Lett 2 006;27:679–82.<br />
479. Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, et al. Low-dose<br />
hormonal contraception after liver transplantation. Transplant Proc<br />
2007;39:1530–2.<br />
480. Fedorkow DM, Corenblum B, Shaffer EA. Cholestasis induced by<br />
oestrogen after liver transplantation. BMJ 1989;299:1080–1.<br />
481. Back DJ, Bates M, Bowden A, et al. The interaction of phenobarbital<br />
and other anticonvulsants with oral contraceptive steroid therapy.<br />
Contraception 1980;22:495–503.<br />
482. Doose DR, Wang S, Padmanabhan M, et al. Effects of topiramate<br />
or carbamazepine on the pharmacokinetics of an oral contraceptive<br />
containing norethindrone and ethinyl estradiol in healthy obese and<br />
nonobese female subjects. Epilepsia 2003;44:540–9.<br />
483. Fattore C, Cipolla G, Gatti G, et al. Induction of ethinylestradiol<br />
and levonorgestrel metabolism by oxcarbazepine in healthy women.<br />
Epilepsia 1999;40:783–7.<br />
484. Rosenfeld WE, Doose DR, Walker SA, Nayak RK. Effect of topiramate<br />
on the pharmacokinetics of an oral contraceptive containing<br />
norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia<br />
1997;38:317–23.<br />
485. Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives<br />
induce lamotrigine metabolism: evidence from a double-blind, placebocontrolled<br />
trial. Epilepsia 2007;48:484–9.<br />
486. Contin M, Albani F, Ambrosetto G, et al. Variation in lamotrigine<br />
plasma concentrations with hormonal contraceptive monthly cycles<br />
in partiens with epilepsy. Epilepsia 2006;47:1573–5.<br />
487. Reimers A, Helde G, Brodtkorb E. Ethinyl estradiol, not progestogens,<br />
reduces lamotrigine serum concentrations. Epilepsia<br />
2005;46:1414–7.<br />
488. Sabers A, Buchholt JM, Uldall P, Hansen EL. Lamotrigine plasma levels<br />
reduced by oral contraceptives. Epilepsy Res 2001;47:151–4.<br />
489. Sabers A, Ohman I, Christensen J, Tomson T. Oral contraceptives<br />
reduce lamotrigine plasma levels. Neurology 2003;61:570–1.<br />
490. Back DJ, Breckenridge AM, MacIver M, et al. The effects of ampicillin<br />
on oral contraceptive steroids in women. Br J Clin Pharmacol<br />
1982;14:43–8.<br />
491. Back DJ, Grimmer SF, Orme ML, et al. Evaluation of the Committee<br />
on Safety of Medicines yellow card reports on oral contraceptive-drug<br />
interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol<br />
1988;25:527–32.<br />
492. Back DJ, Tjia J, Martin C, et al. The lack of interaction between<br />
temafloxacin and combined oral contraceptive steroids. Contraception<br />
1991;43:317–23.<br />
493. Bacon JF, Shenfield GM. Pregnancy attributable to interaction between<br />
tetracycline and oral contraceptives. BMJ 1980;280:293.<br />
494. Bainton R. Interaction between antibiotic therapy and contraceptive<br />
medication. Oral Surg Oral Med Oral Pathol 1986;61:453–5.<br />
495. Bollen M. <strong>Use</strong> of antibiotics when taking the oral contraceptive pill<br />
[comment]. Aust Fam Physician 1995;24:928–9.<br />
496. Bromham DR. Knowledge and use of secondary contraception among<br />
patients requesting termination of pregnancy. BMJ 1993;306:556–7.<br />
497. Cote J. Interaction of griseofulvin and oral contraceptives [comment].<br />
J Am Acad Dermatol 1990;22:124–5.<br />
498. Csemiczky G, Alvendal C, Landgren BM. Risk <strong>for</strong> ovulation in women<br />
taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial<br />
treatment with a fluoroquinoline (ofloxacin). Adv Contracept<br />
1996;12:101–9.<br />
499. de Groot AC, Eshuis H, Stricker BH. Inefficiency of oral contraception<br />
during use of minocycline [in Dutch]. Ned Tijdschr Geneeskd<br />
1990;134:1227–9.<br />
500. DeSano EA Jr, Hurley SC. Possible interactions of antihistamines<br />
and antibiotics with oral contraceptive effectiveness. Fertil Steril<br />
1982;37:853–4.<br />
501. Donley TG, Smith RF, Roy B. Reduced oral contraceptive effectiveness<br />
with concurrent antibiotic use: a protocol <strong>for</strong> prescribing antibiotics<br />
to women of childbearing age. Compendium 1990;11:392–6.<br />
502. Friedman CI, Huneke AL, Kim MH, Powell J. The effect of ampicillin<br />
on oral contraceptive effectiveness. Obstet Gynecol 1980;55:33–7.<br />
503. Grimmer SF, Allen WL, Back DJ, et al. The effect of cotrimoxazole on<br />
oral contraceptive steroids in women. Contraception 1983;28:53–9.<br />
504. Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates<br />
and oral antibiotics. J Am Acad Dermatol 1997;36:705–10.<br />
505. Hempel E, Bohm W, Carol W, Klinger G. Enzyme induction by<br />
drugs and hormonal contraception [in German]. Zentralbl Gynakol<br />
1973;95:1451–7.<br />
506. Hempel E, Zorn C, Graf K. Effect of chemotherapy agents and antibiotics<br />
on hormonal contraception [in German]. Z Arztl Forbild (Jena)<br />
1978;72:924–6.<br />
507. Hetenyi G. Possible interactions between antibiotics and oral contraceptives.<br />
Ther Hung 1989;37:86–9.<br />
508. Hughes BR, Cunliffe WJ. Interactions between the oral contraceptive<br />
pill and antibiotics [comment]. Br J Dermatol 1990;122:717–8.